Reducing cholesterol using Inclisiran
28th March 2025Health Innovation NENC were chosen as the lead organisation to support the rollout of Inclisiran, a Novartis therapy, that aims...
Posted inEducating healthcare professionals about familial hypercholesterolaemia
10th October 2024Educating healthcare professionals about familial hypercholesterolaemia: from a local University to a national MOOC The NHS long term plan called...
Posted inImproving access to FH Genetic Testing: GENinCode
30th August 2024The NHS, in its Long-Term Plan, set a goal to identify 25% of people with FH within five years...
Posted inCVD healthy heart check pathway using PocDoc® rapid lipid testing
22nd July 2024PocDoc® is an innovative point of care device which gives a 5 marker lipid panel result within eight minutes via...
Posted inA new focus of lipid-lowering therapy for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic.
5th April 2024Approximately 25-28 % of UK CVD deaths are due to raised cholesterol; every 1.0 mmol/L in LDL-C is associated with...
Posted inLipid Optimisation – the role of a Pharmacy Technician
24th April 2023Pharmacy technicians have a dedicated skill set and knowledge base. This enables them to triage a patient list and make...
Posted in